Susan Hasty, Publisher
Table of Contents . . . March 11th, 1996Non-Subscriber - Summaries Only
Conference Coverage (NCVDG) - LAMPS Shine, Improve Immune Responses to HIV Proteins
Conference Coverage (NCVDG) - New Approach to Genetic Immunization
Conference Coverage (NCVDG) - Phagocytes Key to Eliciting Killer Cells with Peptide Vaccines
Conference Coverage (NCVDG) - Shell Game Enhances Oral Immunogenicity of DNA, Proteins
Biotechnology - Biotechnology and Gene Therapy Subcommittee Established
Cancer Vaccines - Cellular Anti-Tumor Response Elicited by EBV-Immortalized B Cells
Cancer Vaccines - Systemic IL-12 Boosts Effect of IL-2 Producing Cancer Vaccine
Therapy (Anti-Ras) - Peptides Block Ras Function; Potentially Blocks Oncogenic Development
Vaccine Development (HSV-2) - Nucleic Acid Vaccine Protects Mice from Herpes Simplex Virus-2
Vascular Tissue - Scarred Heart Tissue Susceptible to Gene Therapy
Vectors (Alternative) - Cationic Facial Amphiphiles - Nonviral Transfecting Agents
Histopathology (TB) - "Tuberculosis of the Trachea - A Tumorous Form."
Cell Selection (Gene Transfer) - "Cytotoxic Drug Selection of Murine Bone Marrow Cells Following Transfer of the MDR1 (Multidrug Resistance) Gene Increases Gene Expression and Chemoresistance In Vivo."
Gene Transfer (Chemoprotection) - "Gene Transfer of MDR1 into Primary Human CD34+ Enriched Marrow Cells Mediated by an Adenoassociated Virus-Based Vector."
Therapy (Burkitt's Lymphoma) - "A Role for the Interferon-Inducible Protein 10 (IP-10) in Inhibition of Angiogenesis by IL-12."
Antisense Technology - "Antisense Oligodeoxynucleotides Selectively Suppress Expression of the Mutant Alpha 2(I) Collagen Allele in Type IV Osteogenesis Imperfecta Fibroblasts - A Molecular Approach to Therapeutics of Dominant Negative
Cystic Fibrosis - "Gene Therapy for Cystic Fibrosis using Adenovirus Vectors."
Restenosis - "Gene Therapy for Restenosis."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.